FrancophonIA/ELRC3.0 huggingface dataset:
English: What Atosiban SUN looks like and contents of the pack Atosiban SUN 6.75 mg/0.9 ml solution for injection is a clear, colourless solution without particles.
Croatian: Atosiban SUN 6,75 mg/0,9 ml otopina za injekciju je bistra, bezbojna otopina bez čestica.
English: CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT 5 ml (7.5 mg/ml)
Croatian: 5 ml (7,5 mg/ml)
English: If you get any side effects, talk to your doctor, midwife or pharmacist.
Croatian: Ako primijetite bilo koju nuspojavu, potrebno je obavijestiti liječnika, primalju ili ljekarnika.
English: Atosiban SUN 6.75 mg/0.9 ml solution for injection atosiban
Croatian: Atosiban SUN 6,75 mg/0,9 ml otopina za injekciju atosiban
English: Atosiban is administered intravenously in three successive stages: an initial bolus dose (6.75 mg), performed with atosiban 6.75 mg/0.9 ml solution for injection, immediately followed by a continuous high dose infusion (loading infusion 300 micrograms/min) of atosiban 37.5 mg/5 ml concentrate for solution for infusion during three hours, followed by a lower dose of atosiban 37.5 mg/5 ml concentrate for solution for infusion (subsequent infusion 100 micrograms/min) up to 45 hours.
Croatian: (infuzija udarne doze 300 mikrograma/min) atosibana 37,5 mg/5 ml koncentrata za otopinu za infuziju tijekom tri sata, te potom niža doza atosibana 37,5 mg/5 ml koncentrata za otopinu za infuziju (naredna infuzija od 100 mikrograma/min) do 45 sati.
English: CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT 0.9 ml (6.75 mg/0.9 ml)
Croatian: 0,9 ml (6,75 mg /0,9 ml)
English: Atosiban SUN 37.5 mg/5 ml concentrate for solution for infusion atosiban
Croatian: Atosiban SUN 37,5 mg/5 ml koncentrat za otopinu za infuziju atosiban
English: The total dose given during a full course of atosiban therapy should preferably not exceed 330.75 mg of atosiban.
Croatian: Ukupna primijenjena doza tijekom punog tijeka terapije lijekom atosiban ne bi smjela biti veća od
English: Pruritis, Rash
Croatian: Svrbež, osip
English: España Sun Pharma Laboratorios, S.L.
Croatian: Sun Pharma Laboratorios, S.L. Rambla de Catalunya 53-55
English: MARKETING AUTHORISATION NUMBER(S) EU/1/13/852/001
Croatian: BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/13/852/001
English: MARKETING AUTHORISATION NUMBER(S) EU/1/13/852/002
Croatian: BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/13/852/002
English: NAME OF THE MEDICINAL PRODUCT Atosiban SUN 37.5 mg/5 ml concentrate for solution for infusion atosiban
Croatian: Atosiban SUN 37,5 mg/5 ml koncentrat za otopinu za infuziju
English: NAME OF THE MEDICINAL PRODUCT Atosiban SUN 6.75 mg/0.9 ml solution for injection
Croatian: Atosiban SUN 6,75 mg/0,9 ml otopina za injekciju
English: Posology
Croatian: Tahikardia
English: During treatment with Atosiban SUN, your contractions and your unborn baby's heart rate may be monitored.
Croatian: Kontrakcije maternice i brzina otkucaja srca nerođenog djeteta trebaju se nadzirati za vrijeme liječenja
English: Further treatment cycles of Atosiban SUN can be used should contractions recur.
Croatian: Ako se kontrakcije ponovno pojave, mogu se primijeniti dodatni ciklusi liječenja Atosiban SUN-om.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each vial of 0.9 ml solution contains 6.75 mg of atosiban (as acetate).
Croatian: Jedna bočica od 0,9 ml otopine sadrži 6,75 mg atosibana (u obliku atosibanacetata).
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each vial of 5 ml solution contains 37.5 mg of atosiban (as acetate).
Croatian: Jedna bočica od 5 ml otopine sadrži 37,5 mg atosibana (u obliku atosibanacetata).
English: - Feeling dizzy.
Croatian: - otopini Ringerovog laktata
English: 54 mg infusion Up to 45 hours subsequent
Croatian: 54 mg
English: Skin and subcutaneous tissue disorders
Croatian: Hipotenzija, navala vrućine Poremećaji probavnog sustava Mučnina Povraćanje Poremećaji kože i potkožnog tkiva
English: Uncommon (may affect less than 1 in 100 people) - High temperature (fever).
Croatian: Manje često (pojavljuje se u manje od 1 na 100 osoba)
English: PHARMACEUTICAL FORM AND CONTENTS Solution for injection
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA
English: The vials should be inspected visually for particulate matter and discoloration prior to administration.
Croatian: Prije primjene, bočice je potrebno vizualno pregledati na moguću prisutnost čestica i promjenu boje.
English: - If you are pregnant with more than one baby.
Croatian: - Ako imate višeplodnu trudnoću.
English: Rare (may affect less than 1 in 1,000 people) - Your womb may be less able to contract after your baby has been born.
Croatian: Rijetko (pojavljuje se u manje od 1 na 1000 osoba)
English: Uterine haemorrhage, uterine atony
Croatian: Krvarenje iz maternice, atonija maternice
English: Once the vial has been opened, the medicinal product must be used straight away.
Croatian: Lijek se mora upotrijebiti odmah nakon otvaranja bočice.
English: What Atosiban SUN contains - The active substance is atosiban.
Croatian: Sadržaj pakiranja i druge informacije Što Atosiban SUN sadrži
English: Once the vial has been opened, the solution must be used immediately.
Croatian: Otopina se mora upotrijebiti odmah nakon otvaranja bočice.
English: Olanzapine
Croatian: Olanzapin
English: This summary was last updated in 01-2013.
Croatian: Sažetak je posljednji put ažuriran 01.2013.
English: The usual dose range is between 5 and 20 mg per day.
Croatian: Uobičajeni raspon doze je između 5 i 20 mg na dan.
English: Patients over 65 years of age and patients who have problems with their liver or kidneys may need a lower starting dose of 5 mg per day.
Croatian: Bolesnici stariji od 65 godina koji imaju problema s jetrom ili bubrezima možda će trebati nižu početnu dozu od 5 mg na dan.
English: It is available as orodispersible tablets (5, 10, 15 and 20 mg).
Croatian: Dostupan je u obliku raspadljivih tableta za usta (5, 10, 15 i 20 mg).
English: It is known as an ‘atypical' antipsychotic because it is different from the older antipsychotic medicines that have been available since the 1950s.
Croatian: Poznat je kao „atipični” antipsihotik jer je različit od starijih antipsihotika koji su dostupni na tržištu od 1950.
English: Schizophrenia is a mental illness that has a number of symptoms, including disorganised thinking and speech, hallucinations (hearing or seeing things that are not there), suspiciousness and delusions (mistaken beliefs).
Croatian: Shizofrenija je mentalna bolest koja ima brojne simptome, uključujući neorganizirano razmišljanje i govor, halucinacije (bolesnici čuju ili vide nešto čega nema), sumnjičavost i iluzije (pogrešna uvjerenja).
English: Its exact mechanism of action is unknown, but it attaches to several different receptors on the surface of nerve cells in the brain.
Croatian: Točni mehanizam njegovog djelovanja nije poznat, ali vezuje se na različite receptore na površini živčanih stanica u mozgu.
English: It can also be used to prevent the recurrence of these episodes (when symptoms come back) in adults with bipolar disorder (a mental illness with alternating periods of high mood and depression) who have responded to an initial course of treatment.
Croatian: Može se također koristiti za sprječavanje ponovnog pojavljivanja ovih epizoda (ako se simptomi ponovno pojave) u odraslih osoba s bipolarnim poremećajem (mentalnom bolesti s izmjeničnim razdobljima oduševljenja i depresije) koji su reagirali na početni ciklus liječenja.
English: The full EPAR for the reference medicines can also be found on the Agency's website.
Croatian: Cjelovito izvješće EPAR za referentni lijek također se nalazi na internetskim stranicama Agencije.
English: The recommended starting dose of Olanzapine Glenmark Europe depends on the disease being treated: 10 mg per day is used in schizophrenia and in the prevention of manic episodes, and 15 mg per day in the treatment of manic episodes, unless it is used with other medicines, in which case the starting dose can be 10 mg per day.
Croatian: Preporučena početna doza lijeka Olanzapine Glenmark Europe ovisi o bolesti koja se liječi: 10 mg na dan koriste se za liječenje shizofrenije te u prevenciju epizoda manije, a 15 mg na dan u liječenju epizoda manije osim ako se ne koristi s drugim lijekovima pa u tom slučaju početna doza može biti 10 mg na dan.
English: The dose is adjusted according to how well the patient responds to and tolerates the treatment.
Croatian: Doza se prilagođava u skladu s tim kako dobro bolesnik reagira na liječenje te kako ga dobro podnosi.
English: This disrupts signals transmitted between brain cells by ‘neurotransmitters', chemicals that allow nerve cells to communicate with each other.
Croatian: To prekida signale koji se prenose između stanica mozga putem „neurotransmitera”, kemikalija koje omogućavaju da živčane stanice komuniciraju jedna s drugom.
English: Since these neurotransmitters are involved in schizophrenia and in bipolar disorder, olanzapine helps to normalise the activity of the brain, reducing the symptoms of these diseases.
Croatian: S obzirom da su ti neurotransmiteri uključeni u shizofreniju i bipolarne poremećaje, olanzapin pomaže pri normalizaciji moždane aktivnost smanjujući simptome ovih bolesti.
English: Medicines are bioequivalent when they produce the same levels of the active substance in the body.
Croatian: Dva su lijeka bioekvivalentna kada u tijelu proizvode iste razine djelatne tvari.
English: The orodispersible tablets are taken by being placed on the tongue, where they disintegrate in the saliva, or by mixing them in water before swallowing.
Croatian: Raspadljive tablete za usta uzimaju se tako što se stave na jezik gdje ih razgradi slina ili se miješaju s vodom prije gutanja.
English: It is thought that olanzapine's beneficial effect is due to it blocking receptors for the neurotransmitters 5-hydroxytryptamine (also called serotonin) and dopamine.
Croatian: Smatra se da se korist olanzapina uglavnom temelji na inhibiranju receptora za neurotransmitere 5-hidroksitriptamina (također zvan serotonin) i dopamin.
English: The full EPAR for Olanzapine Glenmark Europe can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku Olanzapine Glenmark Europe (EPAR) nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Olanzapine Glenmark Europe is also effective in maintaining improvement in patients who have responded to an initial course of treatment.
Croatian: Olanzapine Glenmark Europe također je djelotvoran u održavanju poboljšanja u bolesnika koji su reagirali na početni ciklus liječenja.
English: This means that Olanzapine Glenmark Europe is similar to ‘reference medicines' already authorised in the European Union (EU) called Zyprexa and Zyprexa Velotabs.
Croatian: To znači da je Olanzapine Glenmark Europe sličan „referentnom lijeku” koji je već odobren u Europskoj uniji (EU) pod nazivom Zyprexa i Zyprexa Velotabs.
English: Olanzapine Glenmark Europe is also used to treat moderate to severe manic episodes (extremely high mood) in adults.
Croatian: Olanzapine Glenmark Europe se također koristi za liječenje umjerenih do teških epizoda manije (ekstremno dobrog raspoloženja) u odraslih osoba.
English: This is a summary of the European public assessment report (EPAR) for Olanzapine Glenmark Europe.
Croatian: Ovo je sažetak Europskoga javnog izvješća o ocjeni dokumentacije (EPAR) za lijek Olanzapine Glenmark Europe.
English: Because Olanzapine Glenmark Europe is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as the reference medicines.
Croatian: Budući da je Olanzapine Glenmark Europe generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
English: The European Commission granted a marketing authorisation valid throughout the EU for Olanzapine Glenmark Europe on 3 December 2009.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje za lijek Olanzapine Glenmark Europe vrijedi na prostoru Europske unije od 3. prosinca 2009.
English: Therefore, the CHMP's view was that, as for Zyprexa and Zyprexa Velotab, the benefit outweighs the identified risk.
Croatian: Stoga je stav CHMP-a kako koristi lijekova Zyprexa i Zyprexa Velotab nadmašuju utvrđene rizike.
English: For more information about treatment with Olanzapine Glenmark Europe, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Glenmark Europe pročitajte u uputama o lijeku (također dio EPAR-a) odnosno obratite se svom liječniku ili ljekarniku.
English: Olanzapine Glenmark Europe is used to treat adults with schizophrenia.
Croatian: Olanzapine Glenmark Europe koristi se za liječenje odraslih bolesnika sa shizofrenijom.
English: Olanzapine Glenmark Europe is a ‘generic medicine'.
Croatian: Olanzapine Glenmark Europe je „generički lijek”.
English: The active substance in Olanzapine Glenmark Europe, olanzapine, is an antipsychotic medicine.
Croatian: Djelatna tvar u lijeku Olanzapine Glenmark Europe, olanzapin, je antipsihotik.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Olanzapine Glenmark Europe.
Croatian: Objašnjava kako je Povjerenstvo za lijekove za primjenu kod ljudi (CHMP) ocijenilo lijek Olanzapine Glenmark Europe da bi donijelo mišljenje u korist davanja odobrenja za stavljanje na tržište i preporučilo uvjete za njegovu primjenu.
English: Because Olanzapine Glenmark Europe is a generic medicine, studies have been limited to tests to determine that it is bioequivalent to the reference medicines, Zyprexa and Zyprexa Velotab.
Croatian: Budući da je Olanzapine Glenmark Europe generički lijek, ispitivanja su na bolesnicima bila ograničena na utvrđivanje činjenice je li riječ o bioekvivalentnom lijeku referentnim lijekovima Zyprexy i Zyprexa Velotab.
English: Olanzapine Glenmark Europe is a medicine containing the active substance olanzapine.
Croatian: Olanzapine Glenmark Europe je lijek koji sadrži djelatnu tvar olanzapin.
English: The CHMP concluded that, in accordance with EU requirements, Olanzapine Glenmark Europe has been shown to have comparable quality and to be bioequivalent to Zyprexa and Zyprexa Velotab.
Croatian: Povjerenstvo za lijekove za primjenu kod ljudi (CHMP) pri Agenciji zaključilo je kako, u skladu s preduvjetima EU-a, lijek Olanzapine Glenmark Europe posjeduje usporedivu kvalitetu te je bioekvivalentan s lijekovima Zyprexa i Zyprexa Velotab.
English: What are the benefits and risks of Olanzapine Glenmark Europe?
Croatian: Koje su koristi i rizici lijeka Olanzapine Glenmark Europe?
English: The Committee recommended that Olanzapine Glenmark Europe be given marketing authorisation.
Croatian: Povjerenstvo je preporučilo izdavanje odobrenja za stavljanje u promet lijeka Olanzapine Glenmark Europe.
English: Other information about Olanzapine Glenmark Europe
Croatian: Ostale informacije o lijeku Olanzapine Glenmark Europe
English: Why has Olanzapine Glenmark Europe been approved?
Croatian: Zašto je Olanzapine Glenmark Europe odobren?
English: What is Olanzapine Glenmark Europe?
Croatian: Što je Olanzapine Glenmark Europe?
English: What is Olanzapine Glenmark Europe used for?
Croatian: Za što se Olanzapine Glenmark Europe koristi?
English: How is Olanzapine Glenmark Europe used?
Croatian: Kako se Olanzapine Glenmark Europe koristi?
English: How does Olanzapine Glenmark Europe work?
Croatian: Kako djeluje Olanzapine Glenmark Europe?
English: How has Olanzapine Glenmark Europe been studied?
Croatian: Kako je Olanzapine Glenmark Europe ispitivan?
English: Strength Pharmaceutical Form Route of Administration
Croatian: (Zaštićeno) ime Jačina Farmaceutski oblik
English: 1 bottle+3 measuring spoons (1g,150mg, 100mg)
Croatian: + 3mjerne žličice. (1g,150mg, 100mg)
English: EU/1/06/379/001 Cystadane
Croatian: EU/1/06/379/001 Cystadane oralni prašak Primjena kroz usta.
English: Oral use bottle (HDPE)
Croatian: boca (HDPE)
English: • Take one tablet every morning.
Croatian: • Uzmite jednu tabletu svako ujutro.
English: Date of first authorisation: 21 March 2018
Croatian: Datum prvog odobrenja: 21. ožujka 2018.
English: Steglatro should be taken orally once daily in the morning, with or without food.
Croatian: Steglatro treba uzimati peroralno jedanput na dan, ujutro, s hranom ili bez nje.
English: Do not take a double dose (two doses on the same day) to make up for a forgotten dose.
Croatian: Nemojte uzeti dvostruku dozu (dvije doze u istom danu) kako biste nadoknadili zaboravljenu dozu.
English: †, 95% CI)
Croatian: † i 95% CI)
English: Hispanic or Latino patients comprised 24.2% of the population.
Croatian: Bolesnici hispanoameričkog ili latinoameričkog podrijetla činili su 24,2% populacije.
English: It is not known if this medicine is safe and effective when used in children and adolescents under 18 years of age.
Croatian: Nije poznato je li ovaj lijek siguran i učinkovit kada ga uzimaju djeca i adolescenti mlađi od 18 godina.
English: Your doctor may decide to temporarily or permanently stop your treatment with Steglatro.
Croatian: Vaš će liječnik možda odlučiti privremeno ili trajno prekinuti liječenje lijekom Steglatro.
English: Effects of age, body weight, gender, and race
Croatian: Učinci dobi, tjelesne težine, spola i rase
English: Patients should not take two doses of Steglatro on the same day.
Croatian: Bolesnici ne smiju uzeti dvije doze lijeka Steglatro u istom danu.
English: • Swallow the tablet; if you have difficulties with swallowing, the tablet can be broken or crushed.
Croatian: • Progutajte tabletu; ako imate poteškoća s gutanjem, tabletu možete prelomiti ili zdrobiti.
English: (For study results with respect to combinations and effects on glycaemic control see sections 4.4, 4.5, and 5.1.)
Croatian: (Za rezultate ispitivanja koji se odnose na kombinacije i učinke na regulaciju glikemije vidjeti dijelove 4.4, 4.5 i 5.1).
English: Talk with your doctor about the best way to feed your baby if you take Steglatro.
Croatian: Razgovarajte sa svojim liječnikom o najboljem načinu hranjenja svog djeteta dok uzimate Steglatro.
English: Try to take it at the same time; this will help you remember to take it.
Croatian: Pokušajte uzimati lijek svaki dan u isto vrijeme; tako ćete se lakše sjetiti da ga trebate uzeti.
English: • in addition to other medicinal products for the treatment of diabetes.
Croatian: • kao dodatak drugim lijekovima za liječenje dijabetesa.
English: • feeling dizzy, light-headed, or weak, especially when you stand up
Croatian: • omaglicu, ošamućenost ili slabost, osobito pri ustajanju,
English: It is not known if Steglatro can harm your unborn baby.
Croatian: Nije poznato može li Steglatro naškoditi nerođenom djetetu.
English: It is important to check your feet regularly and adhere to any other advice regarding foot care and adequate hydration given by your healthcare professional.
Croatian: Važno je da redovito pregledavate svoja stopala i da se pridržavate svih drugih savjeta o njezi stopala i primjerenoj hidraciji koje su vam dali zdravstveni radnici.
English: Warnings and precautions Talk to your doctor, pharmacist, or nurse before and while taking Steglatro if you:
Croatian: Upozorenja i mjere opreza Obratite se svom liječniku, ljekarniku ili medicinskoj sestri prije i za vrijeme uzimanja lijeka Steglatro:
English: If any of the above apply to you (or you are not sure), tell your doctor.
Croatian: Ako se bilo što od navedenoga odnosi na Vas (ili niste sigurni), obratite se svom liječniku.
English: The safety and efficacy of ertugliflozin in children under 18 years of age have not been established.
Croatian: Sigurnost i djelotvornost ertugliflozina u djece mlađe od 18 godina nisu ustanovljene.
English: • might be at risk of dehydration (for example, if you are taking medicines that increase urine production [diuretics] or lower blood pressure or if you are over 65 years old).
Croatian: • ako bi mogao postojati rizik od dehidracije (primjerice, ako uzimate lijekove koji povećavaju proizvodnju mokraće [diuretike] ili snižavaju krvni tlak ili ako ste stariji od 65 godina).
English: • increased levels of “ketone bodies” in your urine or blood
Croatian: • povišene razine „ketonskih tijela“ u mokraći ili krvi,
English: See Section 4.4.
Croatian: * Vidjeti dio 4.4.
English: Contact a doctor or the nearest hospital straight away if you have any of the following serious side effects:
Croatian: Odmah se obratite liječniku ili otiđite u najbližu bolnicu ako imate bilo koju od sljedećih ozbiljnih nuspojava:
English: • Steglatro can be used alone or with some other medicines that lower blood sugar.
Croatian: • Steglatro se može uzimati samostalno ili u kombinaciji s nekim drugim lijekovima koji snizuju razinu šećera u krvi.
English: Other medicines and Steglatro
Croatian: Drugi lijekovi i Steglatro
English: This can lead to serious medical problems like heart disease, kidney disease, blindness and poor circulation.
Croatian: To može dovesti do ozbiljnih zdravstvenih tegoba kao što su bolest srca, bolest bubrega, sljepoća i loša cirkulacija.
English: What Steglatro looks like and contents of the pack
Croatian: Kako Steglatro izgleda i sadržaj pakiranja
English: • blood tests may show changes related to kidney function (such as ‘creatinine')
Croatian: • nalazi krvnih pretraga mogu pokazivati promjene povezane s funkcijom bubrega (poput razina „kreatinina“)
English: This finding was attributed to carbohydrate malabsorption leading to altered calcium homeostasis and was not considered relevant to human risk.
Croatian: Taj se nalaz pripisao malapsorpciji ugljikohidrata koja je izmijenila homeostazu kalcija i nije se smatrao relevantnim za rizik kod ljudi.
English: Patients had an average age of 57.8 years (range 21 years to 87 years), with 25.8% of patients ≥ 65 years of age and 4.5% ≥ 75 years of age.
Croatian: Prosječna dob bolesnika iznosila je 57,8 godina (raspon: 21 - 87 godina), s time da je 25,8% bolesnika bilo u dobi od ≥ 65 godina, a 4,5% njih u dobi od ≥ 75 godina.
English: Do not use Steglatro if you are pregnant.
Croatian: Nemojte uzimati Steglatro ako ste trudni.
English: • as monotherapy in patients for whom the use of metformin is considered inappropriate due to intolerance or contraindications.
Croatian: • kao monoterapija u bolesnika u kojih se primjena metformina ne smatra prikladnom zbog nepodnošenja ili kontraindikacija
English: Do not drive or use any tools or machines if you feel dizzy while taking Steglatro.
Croatian: Nemojte upravljati vozilima, rukovati alatima niti raditi sa strojevima ako osjećate omaglicu dok uzimate Steglatro.
English: The mean daily dose of glimepiride was 3.0 mg (see Table 4).
Croatian: Srednja dnevna doza glimepirida iznosila je 3,0 mg (vidjeti Tablicu 4).
English: In patients where DKA is suspected or diagnosed, treatment with ertugliflozin should be discontinued immediately.
Croatian: U bolesnika u kojih se posumnja na DKA ili se DKA dijagnosticira, liječenje ertugliflozinom potrebno je odmah prekinuti.
English: Treatment with ertugliflozin may be restarted when the ketone values are normal and the patient's condition has stabilised.
Croatian: Liječenje ertugliflozinom može se ponovno započeti kada se razine ketona vrate u normalu i stanje bolesnika stabilizira.
English: The most commonly reported adverse reactions across the clinical program were vulvovaginal mycotic infection and other female genital mycotic infections.
Croatian: Najčešće prijavljene nuspojave u cjelokupnom programu kliničkih ispitivanja bile su vulvovaginalna gljivična infekcija i druge genitalne gljivične infekcije u žena.
English: Because of how this medicine works, your urine will test positive for sugar (glucose) while you are on this medicine.
Croatian: Zbog načina na koji ovaj lijek djeluje, nalazi pretraga mokraće bit će pozitivni na šećer (glukozu) dok uzimate ovaj lijek.